Sanofi Acquires Dynavax for $2.2 Billion to Boost Vaccine Portfolio
French drugmaker Sanofi agrees to purchase U.S. vaccines company Dynavax Technologies for $2.2 billion, gaining access to hepatitis B vaccine and experimental shingles shot.
NOTRELOAD AI
Snowflake Eyes App Monitoring Startup Observe for $1B
Snowflake eyes $1B Observe acquisition to compete with Datadog and Splunk, but high consumption costs raise questions about viability.
FDA Approves AQVESME: First Treatment for Thalassemia Anemia
The FDA has approved Agios’ AQVESME (mitapivat), the first medicine for treating anemia in adults with alpha or beta-thalassemia, offering hope for thousands of patients.
Apple CEO Tim Cook Invests $3 Million in Struggling Nike Stock
Apple CEO Tim Cook purchases 50,000 Nike shares worth nearly $3 million following the company's earnings decline, signaling confidence as a board member and lead independent director.
Patient Death in Pfizer's Hympavzi Trial Raises Safety Questions for Hemophilia Treatment
Pfizer investigates death of hemophilia patient in Hympavzi trial after thrombotic stroke. Company says no expected safety impact for approved use.
FCC Bans Chinese DJI Drones Over Security Concerns in U.S.
The FCC has officially banned new DJI and Autel drones from the U.S. market, citing national security concerns.